Taken together, SIRT2 may have a significant tumor suppressive role during early carcinogenesis of breast cancer, but conversely in advanced cancer, its overexpression portends more aggressive phenotype, and SIRT2 inhibition has anticancer activities. The gene discussed is SIRT2; the disease is breast carcinoma.